DaVita Inc. (0I7E.L)
USD 140.53
(-0.62%)
USD 140.53
(-0.62%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.82 Billion USD | -9.57% |
| 2022 | 3.4 Billion USD | -6.75% |
| 2021 | 3.64 Billion USD | 2.37% |
| 2020 | 3.56 Billion USD | 2.53% |
| 2019 | 3.47 Billion USD | 8.25% |
| 2018 | 3.2 Billion USD | -0.84% |
| 2017 | 3.23 Billion USD | -21.03% |
| 2016 | 4.09 Billion USD | 3.57% |
| 2015 | 3.95 Billion USD | 7.65% |
| 2014 | 3.67 Billion USD | 3.09% |
| 2013 | 3.56 Billion USD | 36.75% |
| 2012 | 2.6 Billion USD | 23.5% |
| 2011 | 2.11 Billion USD | 7.02% |
| 2010 | 1.97 Billion USD | 6.05% |
| 2009 | 1.86 Billion USD | 6.92% |
| 2008 | 1.73 Billion USD | 3.94% |
| 2007 | 1.67 Billion USD | 12.31% |
| 2006 | 1.49 Billion USD | 58.77% |
| 2005 | 938.67 Million USD | 26.25% |
| 2004 | 743.52 Million USD | 8.41% |
| 2003 | 685.86 Million USD | 7.68% |
| 2002 | 636.94 Million USD | 15.79% |
| 2001 | 550.1 Million USD | 21.13% |
| 2000 | 454.14 Million USD | 0.45% |
| 1999 | 452.11 Million USD | 4.61% |
| 1998 | 432.2 Million USD | 196.64% |
| 1997 | 145.7 Million USD | 63.89% |
| 1996 | 88.9 Million USD | 175.23% |
| 1995 | 32.3 Million USD | -3.29% |
| 1994 | 33.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 991.57 Million USD | 22.1% |
| 2024 Q3 | 1.11 Billion USD | 27.97% |
| 2024 Q2 | 868.76 Million USD | -12.39% |
| 2023 Q1 | 814.51 Million USD | -1.65% |
| 2023 Q3 | 1.05 Billion USD | 11.59% |
| 2023 Q4 | 812.1 Million USD | -22.95% |
| 2023 FY | 3.07 Billion USD | -9.57% |
| 2023 Q2 | 944.52 Million USD | 15.96% |
| 2022 Q2 | 909.96 Million USD | 13.88% |
| 2022 Q1 | 799.02 Million USD | -9.59% |
| 2022 FY | 3.4 Billion USD | -6.75% |
| 2022 Q3 | 863.13 Million USD | -5.15% |
| 2022 Q4 | 828.2 Million USD | -4.05% |
| 2021 Q2 | 951.23 Million USD | 7.89% |
| 2021 Q1 | 881.67 Million USD | 3.92% |
| 2021 Q3 | 929.73 Million USD | -2.26% |
| 2021 Q4 | 883.74 Million USD | -4.95% |
| 2021 FY | 3.64 Billion USD | 2.37% |
| 2020 Q3 | 952.34 Million USD | 6.36% |
| 2020 FY | 3.56 Billion USD | 2.53% |
| 2020 Q2 | 895.41 Million USD | 3.42% |
| 2020 Q1 | 865.78 Million USD | -3.58% |
| 2020 Q4 | 848.44 Million USD | -10.91% |
| 2019 FY | 3.47 Billion USD | 8.25% |
| 2019 Q2 | 884.95 Million USD | 13.72% |
| 2019 Q4 | 897.95 Million USD | -1.64% |
| 2019 Q1 | 778.17 Million USD | -2.0% |
| 2019 Q3 | 912.9 Million USD | 3.16% |
| 2018 Q1 | 813.85 Million USD | -3.02% |
| 2018 Q4 | 794.05 Million USD | 1.34% |
| 2018 Q2 | 817.86 Million USD | 0.49% |
| 2018 Q3 | 783.56 Million USD | -4.19% |
| 2018 FY | 3.2 Billion USD | -0.84% |
| 2017 Q4 | 839.22 Million USD | -15.81% |
| 2017 Q3 | 996.85 Million USD | -2.04% |
| 2017 FY | 3.23 Billion USD | -21.03% |
| 2017 Q1 | 974.46 Million USD | -4.46% |
| 2017 Q2 | 1.01 Billion USD | 4.42% |
| 2016 Q1 | 998.8 Million USD | -1.93% |
| 2016 Q4 | 1.01 Billion USD | -1.25% |
| 2016 Q3 | 1.03 Billion USD | -1.31% |
| 2016 FY | 4.09 Billion USD | 3.57% |
| 2016 Q2 | 1.04 Billion USD | 4.79% |
| 2015 Q3 | 1.02 Billion USD | 3.65% |
| 2015 Q2 | 988.54 Million USD | 6.83% |
| 2015 Q1 | 925.35 Million USD | -3.77% |
| 2015 FY | 3.95 Billion USD | 7.65% |
| 2015 Q4 | 1.01 Billion USD | -0.6% |
| 2014 Q3 | 925.29 Million USD | -0.07% |
| 2014 Q1 | 863 Million USD | -7.74% |
| 2014 Q4 | 961.55 Million USD | 3.92% |
| 2014 FY | 3.67 Billion USD | 3.09% |
| 2014 Q2 | 925.95 Million USD | 7.29% |
| 2013 FY | 3.56 Billion USD | 36.75% |
| 2013 Q4 | 935.37 Million USD | 3.44% |
| 2013 Q3 | 904.25 Million USD | 5.47% |
| 2013 Q2 | 857.35 Million USD | -2.09% |
| 2013 Q1 | 875.65 Million USD | 12.97% |
| 2012 Q3 | 622.04 Million USD | 0.74% |
| 2012 Q1 | 603.47 Million USD | -6.93% |
| 2012 Q2 | 617.49 Million USD | 2.32% |
| 2012 Q4 | 775.09 Million USD | 24.6% |
| 2012 FY | 2.6 Billion USD | 23.5% |
| 2011 Q2 | 546.3 Million USD | 11.5% |
| 2011 Q4 | 648.4 Million USD | 4.88% |
| 2011 FY | 2.11 Billion USD | 7.02% |
| 2011 Q1 | 489.96 Million USD | -4.75% |
| 2011 Q3 | 618.23 Million USD | 13.17% |
| 2010 FY | 1.97 Billion USD | 6.05% |
| 2010 Q4 | 514.4 Million USD | 1.81% |
| 2010 Q3 | 505.26 Million USD | 6.07% |
| 2010 Q2 | 476.35 Million USD | -0.06% |
| 2010 Q1 | 476.62 Million USD | 0.73% |
| 2009 FY | 1.86 Billion USD | 6.92% |
| 2009 Q4 | 473.15 Million USD | -1.02% |
| 2009 Q3 | 478.05 Million USD | 2.33% |
| 2009 Q2 | 467.16 Million USD | 5.75% |
| 2009 Q1 | 441.75 Million USD | -1.76% |
| 2008 Q2 | 434.01 Million USD | 4.71% |
| 2008 Q1 | 414.51 Million USD | -3.01% |
| 2008 FY | 1.73 Billion USD | 3.94% |
| 2008 Q4 | 449.66 Million USD | 1.85% |
| 2008 Q3 | 441.48 Million USD | 1.72% |
| 2007 Q1 | 396.58 Million USD | -0.87% |
| 2007 Q4 | 427.36 Million USD | -0.18% |
| 2007 Q3 | 428.13 Million USD | 1.52% |
| 2007 Q2 | 421.72 Million USD | 6.34% |
| 2007 FY | 1.67 Billion USD | 12.31% |
| 2006 FY | 1.49 Billion USD | 58.77% |
| 2006 Q4 | 400.06 Million USD | 5.28% |
| 2006 Q3 | 379.99 Million USD | 4.15% |
| 2006 Q2 | 364.84 Million USD | 5.62% |
| 2006 Q1 | 345.41 Million USD | 12.83% |
| 2005 Q2 | 213.69 Million USD | 6.84% |
| 2005 FY | 938.67 Million USD | 26.25% |
| 2005 Q4 | 306.14 Million USD | 39.9% |
| 2005 Q3 | 218.82 Million USD | 2.4% |
| 2005 Q1 | 200 Million USD | 1.83% |
| 2004 FY | 743.52 Million USD | 8.41% |
| 2004 Q4 | 196.41 Million USD | -1.11% |
| 2004 Q3 | 198.62 Million USD | 12.54% |
| 2004 Q2 | 176.49 Million USD | 2.61% |
| 2004 Q1 | 172 Million USD | -23.04% |
| 2003 Q3 | 165.38 Million USD | 7.47% |
| 2003 Q2 | 153.89 Million USD | 7.55% |
| 2003 FY | 685.86 Million USD | 7.68% |
| 2003 Q1 | 143.09 Million USD | -23.08% |
| 2003 Q4 | 223.48 Million USD | 35.13% |
| 2002 Q2 | 142.12 Million USD | 4.48% |
| 2002 Q1 | 136.03 Million USD | -1.98% |
| 2002 Q3 | 172.75 Million USD | 21.55% |
| 2002 FY | 636.94 Million USD | 15.79% |
| 2002 Q4 | 186.03 Million USD | 7.69% |
| 2001 Q3 | 156.98 Million USD | 21.61% |
| 2001 FY | 550.1 Million USD | 21.13% |
| 2001 Q1 | 125.24 Million USD | 7.65% |
| 2001 Q4 | 138.77 Million USD | -11.6% |
| 2001 Q2 | 129.09 Million USD | 3.08% |
| 2000 Q4 | 116.33 Million USD | 2.23% |
| 2000 Q1 | 112.81 Million USD | -1.22% |
| 2000 Q3 | 113.8 Million USD | 2.34% |
| 2000 FY | 454.14 Million USD | 0.45% |
| 2000 Q2 | 111.19 Million USD | -1.44% |
| 1999 Q2 | 104.5 Million USD | -19.68% |
| 1999 FY | 452.11 Million USD | 4.61% |
| 1999 Q1 | 130.1 Million USD | 12.16% |
| 1999 Q4 | 114.21 Million USD | -1.71% |
| 1999 Q3 | 116.2 Million USD | 11.2% |
| 1998 Q1 | 93.4 Million USD | 113.73% |
| 1998 FY | 432.2 Million USD | 196.64% |
| 1998 Q4 | 116 Million USD | -1.44% |
| 1998 Q3 | 117.7 Million USD | 12.1% |
| 1998 Q2 | 105 Million USD | 12.42% |
| 1997 FY | 145.7 Million USD | 63.89% |
| 1997 Q3 | 38.2 Million USD | 11.05% |
| 1997 Q2 | 34.4 Million USD | 19.03% |
| 1997 Q1 | 28.9 Million USD | 7.84% |
| 1997 Q4 | 43.7 Million USD | 14.4% |
| 1996 Q1 | 16.9 Million USD | 17.36% |
| 1996 Q2 | 21.3 Million USD | 26.04% |
| 1996 Q3 | 23.8 Million USD | 11.74% |
| 1996 Q4 | 26.8 Million USD | 12.61% |
| 1996 FY | 88.9 Million USD | 175.23% |
| 1995 Q4 | 14.4 Million USD | 10.77% |
| 1995 Q3 | 13 Million USD | -47.58% |
| 1995 FY | 32.3 Million USD | -3.29% |
| 1995 Q2 | 24.8 Million USD | 0.0% |
| 1995 Q1 | 24.8 Million USD | 0.4% |
| 1994 Q4 | 24.7 Million USD | 0.0% |
| 1994 FY | 33.4 Million USD | 0.0% |
| 1994 Q3 | 24.7 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -1793.693% |
| Accuray Incorporated | 143.12 Million USD | -2569.371% |
| Align Technology, Inc. | 2.72 Billion USD | -40.449% |
| Elevance Health Inc. | 47.01 Billion USD | 91.873% |
| AxoGen, Inc. | 127.87 Million USD | -2887.652% |
| Boston Scientific Corporation | 9.84 Billion USD | 61.21% |
| CVS Health Corporation | 54.43 Billion USD | 92.981% |
| Cardinal Health, Inc. | 7.41 Billion USD | 48.47% |
| Centene Corporation | 153.99 Billion USD | 97.519% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 93.062% |
| Hologic, Inc. | 2.23 Billion USD | -70.723% |
| Humana Inc. | 106.44 Billion USD | 96.411% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -74.451% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -13.538% |
| Masimo Corporation | 1 Billion USD | -280.711% |
| McKesson Corporation | 12.58 Billion USD | 69.641% |
| Patterson Companies, Inc. | 1.38 Billion USD | -176.794% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -29.025% |
| ResMed Inc. | 2.6 Billion USD | -46.445% |
| Henry Schein, Inc. | 3.65 Billion USD | -4.641% |
| Teladoc Health, Inc. | 1.84 Billion USD | -107.363% |
| Universal Health Services, Inc. | 1.17 Billion USD | -225.038% |
| Veeva Systems Inc. | 1.68 Billion USD | -126.546% |
| Baxter International Inc. | 4.97 Billion USD | 23.207% |
| Becton, Dickinson and Company | 8.82 Billion USD | 56.699% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 19.221% |
| Danaher Corporation | 14.12 Billion USD | 72.96% |
| Stryker Corporation | 13.05 Billion USD | 70.743% |
| Medtronic plc | 21.27 Billion USD | 82.041% |